online prescription solutions
online discount medstore
pills online
buy lorazepam without prescription
xanax for sale
buy xanax without prescription
buy ambien without prescription
ambien for sale
buy modafinil without prescription
buy phentermine without prescription
modafinil for sale
phentermine for sale
lorazepam for sale
buy lexotan without prescription
bromazepam for sale
xenical for sale
buy stilnox without prescription
valium for sale
buy prosom without prescription
buy mefenorex without prescription
buy sildenafil citrate without prescription
buy adipex-p without prescription
librium for sale
buy restoril without prescription
buy halazepam without prescription
cephalexin for sale
buy zoloft without prescription
buy renova without prescription
renova for sale
terbinafine for sale
dalmane for sale
buy lormetazepam without prescription
nobrium for sale
buy klonopin without prescription
priligy dapoxetine for sale
buy prednisone without prescription
buy aleram without prescription
buy flomax without prescription
imovane for sale
adipex-p for sale
buy niravam without prescription
seroquel for sale
carisoprodol for sale
buy deltasone without prescription
buy diazepam without prescription
zopiclone for sale
buy imitrex without prescription
testosterone anadoil for sale
buy provigil without prescription
sonata for sale
nimetazepam for sale
buy temazepam without prescription
buy xenical without prescription
buy famvir without prescription
buy seroquel without prescription
rivotril for sale
acyclovir for sale
loprazolam for sale
buy nimetazepam without prescription
buy prozac without prescription
mogadon for sale
viagra for sale
buy valium without prescription
lamisil for sale
camazepam for sale
zithromax for sale
buy clobazam without prescription
buy diflucan without prescription
modalert for sale
diflucan for sale
buy alertec without prescription
buy zyban without prescription
buy serax without prescription
buy medazepam without prescription
buy imovane without prescription
mefenorex for sale
lormetazepam for sale
prednisone for sale
ativan for sale
buy alprazolam without prescription
buy camazepam without prescription
buy nobrium without prescription
mazindol for sale
buy mazindol without prescription
buy mogadon without prescription
buy terbinafine without prescription
diazepam for sale
buy topamax without prescription
cialis for sale
buy tafil-xanor without prescription
buy librium without prescription
buy zithromax without prescription
retin-a for sale
buy lunesta without prescription
serax for sale
restoril for sale
stilnox for sale
lamotrigine for sale

STLR Link Roundup – December 4, 2012

Tighter Digital Protections on the Horizon

The fall-out from the Paula Broadwell investigation has resulted in more than the resignation of CIA Director David Petraeus. It’s resulted in increased scrutiny over government access to electronic data without the use of a warrant. Just this week, Senate
committee has unanimously approved of a measure
amending the Electronic Communications Privacy Act (ECPA) of 1986 which would increase security for e-mails. Instead of an administrative subpoena for certain electronically stored data, the government would need to meet the higher standard of showing probably cause that a crime had been committed. Although the bill is not expected to make it to the House until the new year, for those concerned about lack of protections, it is an
important step in ensuring digital security
in an age where e-mail, Facebook, Twitter, and other internet use have become a pervasive fact of life. Even with the Senate’s recent actions, the area remains murky; recently, a court ruled Twitter was compelled to sell its data in fulfillment of its contract with a data-mining company.

A Compassionate Use of Patent Law
While some companies have become famed for their patent wars, not many companies make the news for refraining from patent litigations. Johnson & Johnson has announced that it will not pursue patent litigation against companies which make a copy of its anti-retroviral drug, Prezista (or generic darunavir), if those generics are going to patients in Africa or developing nations. Johnson & Johnson stated in a press release that ”intellectual property should not be a barrier to ensuring a sustainable supply of medically acceptable darunavir in the world’s poorest countries.” While prices are already reduced to $2.22 per day after J&J licensed its drug to a South African generics manufacturer, this move will hopefully encourage other manufacturers to participate, lowering prices even further. While the move is calculated to help those in need, Johnson
& Johnson has not participated in the new Medicines Patent Pool
which is designed to make intellectual property available by pooling patents for generic makers to use.

An Inconvenient Solution at Doha

With time running out on the Kyoto Protocol, nations are meeting at Doha to discuss the possibility of a new climate deal or at least extending the time commitments on the aging treaty. The Kyoto Protocol mandates binding cuts in carbon emissions for those nations party to the treaty. While the United States never signed the Kyoto Protocol, international climate laws have become increasingly geared towards curbing carbon emissions. Just two years ago, another
UN conference agreed to limit temperature rises to near pre-industrial levels. However, this has proven difficult to accomplish, not the least because several developed nations, including Japan, Russia, and Canada, are pulling out of the treaty or else can use hot air permits to increase their emissions.

Research in Motion Loses Patent Dispute
RIM has lost a patent dispute in an arbitration against Nokia this month concerning its current license agreement. The judgment is not appealable but is enforceable in U.S. Courts, leading RIM to the dilemma of either needing to stop its production of wifi enabled devices or else license the technology from Nokia and pay royalties. The cell-phone maker has already filed suit in the Northern District of California.

Google’s Antitrust Woes
Although the Federal Trade Commission has yet to act, reports have circulated that it is investigating and in talks with Google to resolve concerns over unfair trade practices relating to both its search engine and phone technologies. The European Union is also conducting its own investigation into Google’s business practices.

 

About the Author

Helen Zhu

Helen Zhu is a Submissions Editor for the Columbia Science and Technology Law Review. She is a 3L at Columbia Law School.
blog comments powered by Disqus